CompanyDrug

Betta Pharmaceuticals’ Ensartinib Accepted for FDA Review for First-Line ALK+ NSCLC Treatment

CompanyDrug

CORXEL Gets CDE Green Light for Phase III Aficamten Study in nHCM

CompanyDrug

InnoCare Pharma Receives IND Approval in China for BCL2 Inhibitor Combo Therapy

CompanyDrug

Simcere Pharmaceutical Gets NMPA Approval for Clinical Study of Trispecific Antibody SIM0500

CompanyDrug

Fosun Pharmaceutical Gets NMPA Green Light for Phase I Study of Fibrosis Drug HLX6018

Policy / Regulatory

NMPA Releases 78th Batch of Reference Drugs for Generic Quality Consistency Evaluation

Policy / Regulatory

China’s NHC Outlines Cross-departmental Law Enforcement to Strengthen Medical Supervision

CompanyDeals

Kexing Pharmaceutical Secures Rights for Chia Tai Tianqing’s Generic Ibrance in 11 Countries

CompanyDrug

Kelun-Biotech’s A400 Receives Fast-Track Status from FDA for RET Fusion-Positive NSCLC

CompanyDrug

Sinocelltech Gains NMPA Approval for Clinical Study of SCTB35 in B-Cell Non-Hodgkin’s Lymphoma

CompanyDrug

Huadong Medicine Secures NMPA Approval for HDM1005, Targeting Type 2 Diabetes and Obesity

CompanyDrug

Innovent and HutchMed’s Combination Therapy Set for Priority Review in China for Advanced Endometrial Cancer